A Real-Time In-vivo Method for Studying the Percutaneous Absorption of Volatile Chemicals

References

• Environmental Protection Agency. Exposure Factors Handbook. Washington, DC: EPA/600/P-95/002Ba, 1996.
   Google Scholar
• Daniell W, Stebbins A, Kalman D, O'Donnell JF, Horstman SW. The contributions to solvent uptake by skin and inhalation expo-sure. Am Ind Hyg Assoc J. 1992; 53: 124–9.
   PubMed Web of Science ®Google Scholar
• Paustenbach DJ, Leung H-W. Techniques for assessing the health risks of dermal contact with chemicals in the environment. In: Wang RGM, Knaak JB, Maibach HI (eds). Health Risk Assess-ment. Dermal and Inhalation Exposure and Absorption of Toxi-cants. Boca Raton, FL: CRC Press, 1993: 343-86.
   Google Scholar
• Corley RA, Gordon SM, Wallace LA. Physiologically based phar-macokinetic modeling of the temperature-dependent dermal ab-sorption of chloroform by humans following bath water expo-sures. Toxicol Sci. 2000; 53: 13–23.
   PubMed Web of Science ®Google Scholar
• Poet TS, Thrall ED, Corley RA, et al. Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans. Toxicol Sci. 2000; in press.
   Google Scholar
• Gordon SM, Callahan PJ, Kenny DV, Brinlunan MC, Wallace LA, Pleil JD. Effect of water temperature on dermal exposure to chlo-roform. Environ. Health Perspect. 1998; 106: 337–45.
   PubMed Web of Science ®Google Scholar
• Andersen ME, Krewski D, 'Withey JR. Physiological pharmacold-netics and cancer risk assessment. Cancer Lett. 1993; 69: 1–14.
   Google Scholar
• Environmental Protection Agency. Dermal Exposure Assessment Principles and Applications. Washington, DC: EPA/600/8-91/011B, 1992.
   Google Scholar
• Fiserova-Bergerova V, Pierce JT, Droz PO. Dermal absorption po-tential of industrial chemicals: criteria for skin notation. Am J Ind Med. 1990; 17: 617–35.
   PubMed Web of Science ®Google Scholar
• Jepson GW, McDougal JN. Physiologically based modeling on non steady-state dermal absorption of halogenated methanes from an aqueous solution. Toxicol Appl Pharmacol. 1997; 144: 315–24.
   PubMed Web of Science ®Google Scholar
• Thrall RI), Poet TS, Corley RA. An innovative method to deter-mine percutaneous absorption: real-time breath analysis and physiologically based pharmacokinetic modeling. In: Bronaugh R, Maibach H (eds). Percutaneous Absorption. New York: Marcel Dekker, 1999: 929-37.
   Google Scholar
• Gargas ML. An exhaled breath chamber system for assessing rates of metabolism and rates of gastrointestinal absorption with volatile compounds. J Am Coll Toxicol. 1990; 9: 447–53.
   Google Scholar
• Reitz RH, McDougal JN, Himmelstein MW, Nolan RJ, Schumann AM. Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations. Toxicol Appl Pharmacol. 1988; 95: 185–99.
   PubMed Web of Science ®Google Scholar
• Fisher JW, Mahle D, Abbas R. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanl. Toxicol Appl Phar-macol. 1998; 152: 339–59.
   PubMed Web of Science ®Google Scholar
• Travis CC, Quillen JL, Arms AD. Pharmacokinetics of benzene. Toxicol Appl Pharmacol. 1990;102;400–20.
   PubMed Web of Science ®Google Scholar
• Shatkin J, Szejnwald-Brown H. Pharmacokinetics of the dermal route of exposure to volatile organic chemicals in water: a com-puter simulation model. Environ Res. 1991; 56: 90–108.
   PubMed Web of Science ®Google Scholar
• Chinery RL, Gleason AK. A compartmental model for the pre-diction of breath concentration and absorbed dose of chloroform after exposure while showering. Risk Analysis. 1993; 13: 51–62.
   PubMed Web of Science ®Google Scholar
• McKone TE. Linking a PBPK model for chloroform with mea-sured breath concentrations in showers: implications for dermal exposure models. J Exposure Analysis Environ Epidemiol. 1993; 3: 339–65.
   PubMedGoogle Scholar
• McDougal JN, Jepson GW, Clewell HJ III, MacNaughton MG, An-dersen ME. A physiologically based pharmacokinetic model for dermal absorption of vapors in the rat. Toxicol Appl Pharmacol. 1986; 85: 286–94.
   PubMed Web of Science ®Google Scholar
• McDougal JN, Jepson GW, Clewell HJ III, Gargas ML, Andersen ME. Dermal absorption of organic chemical vapors in rats and hu-mans. Fund Appl Toxicol. 1990; 55: 299–308.
   Google Scholar
• Bronaugh RL. Current issues in the in vitro measurement of per-cutaneous absorption. In: Roberts MS, Walters KW (eds). Dermal Absorption and Toxicity Assessment. New York: Marcel Dekker, 1998: 155-60.
   Google Scholar
• Wester RC, Maibach HI. Regional variation in percutaneous ab-sorption. In: Bronaugh R, Maibach H (eds). Percutaneous Ab-sorption. New York: Marcel Dekker, 1999: 107-16.
   Google Scholar
• Abdel-Rahman MS, Skowronski GA, Turkall RM. A compara-tive study of the kinetics and bioavailability of pure and soil- absorbed benzene, toluene, and m-xylene after dermal expo-sure. In: Wang RGM, Knaak JB, Maibach HI (eds). Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants. CRC Press, Boca Raton, FL: CRC Press, 1993: 105-16.
   Google Scholar
• Wester RC, Maibach HI. Animal models for percutaneous ab-sorption. In: Wang RGM, Knaak JB, Maibach HI, (eds). Health Risk Assessment. Dermal and Inhalation Exposure and Absorp-tion of Toxicants. Boca Raton, FL: CRC Press, 1993: 89-103.
   Google Scholar